NEW YORK—A high-dose oral formulation of calcitriol, called DN 101 and used in combination with docetaxel, is associated with longer survival in men with hormone-refractory prostate cancer (HRPC), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results